PharmaVoice Logo

Healthcare Leaders Hub

Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors

PharmaShots

Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors

Shots: Ref: GlobeNewswire  |   Image: Erasca  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors appeared first on PharmaShots.

Read Full Article
Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date

PharmaShots

Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date

Shots: Ref: Business Wire  |   Image: Savara  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date appeared first on PharmaShots.

Read Full Article
Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1

PharmaShots

Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1

Shots: Ref: GlobeNewswire  |   Image: Belite Bio  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1 appeared first on PharmaShots.

Read Full Article
Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma

PharmaShots

Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma

Shots: Ref: Merck  |   Image: Merck  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma appeared first on PharmaShots.

Read Full Article
Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase

PharmaShots

Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase

When a pharmaceutical or biotech cleanroom is designed, the attention naturally goes to the big systems: the HVAC and its pressure cascade, the room layout and personnel flows, the wall and ceiling panel system, the floor finish and the process equipment. Computers, screens and scanners tend to appear late, often as an item on the… The post Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase appeared first on PharmaShots.

Read Full Article

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Nov 20, 2026, 4:17 PM

Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors

Shots: Ref: GlobeNewswire  |   Image: Erasca  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Erasca Reports Updated P-I (AURORAS-1) Data of ERAS-0015 for RAS-Mutant Solid Tumors appeared first on PharmaShots.

PharmaShots

Nov 20, 2026, 4:10 PM

Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date

Shots: Ref: Business Wire  |   Image: Savara  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Savara Reports the US FDA Will Not Act on Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis by the PDUFA Date appeared first on PharmaShots.

PharmaShots

Nov 20, 2026, 4:05 PM

Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1

Shots: Ref: GlobeNewswire  |   Image: Belite Bio  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Belite Bio Reports Three-Month Extension of the US FDA Review of Tinlarebant NDA for Stargardt Disease Type 1 appeared first on PharmaShots.

PharmaShots

Nov 20, 2026, 4:04 PM

Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma

Shots: Ref: Merck  |   Image: Merck  |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Merck’s Sacituzumab Tirumotecan (Sac-TMT) Meets Primary Endpoint of Overall Survival in P-III TroFuse-015 Trial for Gastroesophageal Adenocarcinoma appeared first on PharmaShots.

Pharma Tech

Nov 20, 2026, 2:59 PM

MSD and Isomorphic join forces to develop oncology drugs 

MSD inks this deal as it looks to offset the looming impact of Keytruda’s patent expiry and secure its long-term growth prospects.

PharmaShots

Nov 20, 2026, 2:48 PM

Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase

When a pharmaceutical or biotech cleanroom is designed, the attention naturally goes to the big systems: the HVAC and its pressure cascade, the room layout and personnel flows, the wall and ceiling panel system, the floor finish and the process equipment. Computers, screens and scanners tend to appear late, often as an item on the… The post Building a Pharma Cleanroom Facility: Why IT Hardware Belongs in the Design Phase appeared first on PharmaShots.

News

Latest industry coverage

Google News

Nov 20, 2026, 8:37 PM

Big Pharma Says AI and Anthropic Tools Shrink Preclinical Drug Discovery Timelines - CASRAI

Big Pharma Says AI and Anthropic Tools Shrink Preclinical Drug Discovery Timelines  CASRAI

Google News

Nov 20, 2026, 7:56 PM

Why Drug Development Disputes Demand a Different Playbook - JD Supra

Why Drug Development Disputes Demand a Different Playbook  JD Supra

Google News

Nov 20, 2026, 6:51 PM

Why powder flowability matters in injectable implant manufacturing - News-Medical

Why powder flowability matters in injectable implant manufacturing  News-Medical

Google News

Nov 20, 2026, 6:38 PM

Mapping psychedelics’ commercial summit - Fierce Pharma

Mapping psychedelics’ commercial summit  Fierce Pharma

Google News

Nov 20, 2026, 6:33 PM

Drugmakers Expand AI Use To Cut Research Timelines - Forbes Middle East

Drugmakers Expand AI Use To Cut Research Timelines  Forbes Middle East

Google News

Nov 20, 2026, 6:00 PM

Pharma Competitive Intelligence Services: Real-Time, - GlobeNewswire

Pharma Competitive Intelligence Services: Real-Time,  GlobeNewswire

Google News

Nov 20, 2026, 5:40 PM

UK-EU deal could signal closer cooperation for pharma - European Pharmaceutical Review

UK-EU deal could signal closer cooperation for pharma  European Pharmaceutical Review

Google News

Nov 20, 2026, 5:39 PM

NSCEB warns US-China biopharma licensing deals risk eroding US drug development pipeline - AllSci

NSCEB warns US-China biopharma licensing deals risk eroding US drug development pipeline  AllSci

Google News

Nov 20, 2026, 5:18 PM

Opinion | Beware of Conflicts With Medical Platforms - WSJ

Opinion | Beware of Conflicts With Medical Platforms  WSJ

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer